Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities:
Net earnings	$ 5,364	$ 2,095
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	1,786	1,502
Amortization (accretion) of purchase accounting adjustments	(1,255)	41
Provision for loan losses	1,250	2,500
Provision for deferred tax expense	845	(77)
Amortization of premiums on securities, net	811	511
Amortization of other investments	7	7
Stock compensation expense	28	14
Restricted stock expense	29	34
Net gain on sale of investment securities	(135)	(99)
Net loss on sale of other real estate owned	93	66
Net write down of other real estate owned	452	0
Change in accrued interest receivable	293	87
Change in accrued interest payable	(98)	(56)
Change in other assets & other liabilities, net	(128)	1,773
Net cash provided by operating activities	9,342	8,398
Cash flows from investing activities:
Net decrease in time deposits in other banks	0	5,164
Proceeds from maturities and calls of securities available-for-sale	49,411	40,654
Proceeds from maturities and calls of securities held-to-maturity	7,698	900
Proceeds from sale of securities available-for-sale	1,703	3,895
Purchases of securities available-for-sale	(53,270)	(84,713)
Purchases of securities held-to-maturity	(30,697)	0
Purchases of other investments	(185)	(5)
Net change in loans	(5,719)	(15,885)
Purchases of premises and equipment	(2,738)	(2,094)
Proceeds from sale of premises and equipment	0	6
Proceeds from sale of other real estate owned	131	614
Net cash used in investing activities	(33,666)	(51,464)
Cash flows from financing activities:
Change in deposits	(10,402)	25,124
Change in securities sold under agreements to repurchase	4,269	2,137
Proceeds from FHLB advances	100	0
Repayments of FHLB advances	(100)	0
Proceeds from exercise of stock options	65	0
Payment of dividends on preferred stock	(800)	(500)
Payment of dividends on common stock	(1,465)	(1,363)
Net cash (used in) provided by financing activities	(8,333)	25,398
Net decrease in cash and cash equivalents	(32,657)	(17,668)
Cash and cash equivalents, beginning of period	83,303	91,907
Cash and cash equivalents, end of period	50,646	74,239
Supplemental information- Noncash items
Accretion Of Warrants	0	99
Transfer of loans to other real estate	425	5,342
Net change in loan to ESOP	0	57
Financed sales of other real estate	$ 150	$ 73